A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

Conditions: Acute Myeloid Leukemias Interventions: Drug: SNDX-5613; Drug: Chemotherapy Regimen; Drug: HiDAC Sponsors: Syndax Pharmaceuticals Not yet recruiting

https://clinicaltrials.gov/study/NCT06226571

Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials